Payment overview · 2025
General Payments
$39.44
2 reported records · 1 companies
Healthcare provider profile · identity verified
Gregory W Rodocker, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · EVANSVILLE, IN · NPI 1821091117
Verified facts
What the public records show
CMS Open Payments records show Gregory W Rodocker, M.D. received $39.44 in general payments during 2025 across 2 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $39.44 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $39.44 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $39.44 | 2 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $39.44 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1166 | 205 |
| Amlodipine Besylate | Amlodipine Besylate | 861 | 158 |
| Levothyroxine Sodium | Levothyroxine Sodium | 764 | 119 |
| Furosemide | Furosemide | 654 | 126 |
| Eliquis | Apixaban | 639 | 57 |
| Lisinopril | Lisinopril | 499 | 96 |
| Omeprazole | Omeprazole | 472 | 100 |
| Metoprolol Succinate | Metoprolol Succinate | 425 | 71 |
| Pantoprazole Sodium | Pantoprazole Sodium | 400 | 56 |
| Potassium Chloride | Potassium Chloride | 392 | 72 |
| Losartan Potassium | Losartan Potassium | 367 | 71 |
| Donepezil Hcl | Donepezil Hcl | 340 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 313 | 62 |
| Buspirone Hcl | Buspirone Hcl | 310 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 296 | 47 |
| Metformin Hcl | Metformin Hcl | 274 | 55 |
| Memantine Hcl | Memantine Hcl | 269 | 45 |
| Gabapentin | Gabapentin | 261 | 52 |
| Escitalopram Oxalate | Escitalopram Oxalate | 252 | 47 |
| Sertraline Hcl | Sertraline Hcl | 233 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 227 | 33 |
| Famotidine | Famotidine | 224 | 41 |
| Citalopram Hbr | Citalopram Hydrobromide | 207 | 32 |
| Trazodone Hcl | Trazodone Hcl | 206 | 44 |
| Simvastatin | Simvastatin | 190 | 36 |
| Allopurinol | Allopurinol | 171 | 33 |
| Carvedilol | Carvedilol | 165 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 164 | 42 |
| Januvia | Sitagliptin Phosphate | 163 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 162 | 34 |
| Meloxicam | Meloxicam | 146 | 28 |
| Warfarin Sodium | Warfarin Sodium | 144 | 22 |
| Mirtazapine | Mirtazapine | 139 | 29 |
| Hydralazine Hcl | Hydralazine Hcl | 124 | 28 |
| Levetiracetam | Levetiracetam | 120 | 17 |
| Tradjenta | Linagliptin | 120 | suppressed |
| Atenolol | Atenolol | 119 | 22 |
| Baclofen | Baclofen | 119 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 118 | 21 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 117 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 27 |
| Ropinirole Hcl | Ropinirole Hcl | 109 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 107 | 37 |
| Alendronate Sodium | Alendronate Sodium | 104 | 24 |
| Myrbetriq | Mirabegron | 102 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 100 | 47 |
| Ondansetron Odt | Ondansetron | 96 | 59 |
| Pravastatin Sodium | Pravastatin Sodium | 91 | 22 |
| Spironolactone | Spironolactone | 89 | 18 |
| Prednisone | Prednisone | 86 | 25 |
| Xarelto | Rivaroxaban | 84 | suppressed |
| Ezetimibe | Ezetimibe | 82 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 81 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 81 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 77 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 76 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 75 | 43 |
| Nystatin | Nystatin | 74 | 38 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 73 | 14 |
| Latanoprost | Latanoprost | 72 | 18 |
| Clonidine Hcl | Clonidine Hcl | 70 | 13 |
| Lorazepam | Lorazepam | 68 | 11 |
| Risperidone | Risperidone | 67 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 66 | suppressed |
| Finasteride | Finasteride | 66 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 65 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 61 | 12 |
| Divalproex Sodium | Divalproex Sodium | 61 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 60 | suppressed |
| Bupropion Xl | Bupropion Hcl | 60 | 13 |
| Glimepiride | Glimepiride | 60 | 18 |
| Montelukast Sodium | Montelukast Sodium | 58 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 56 | 32 |
| Gemtesa | Vibegron | 56 | suppressed |
| Jardiance | Empagliflozin | 56 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 56 | suppressed |
| Aripiprazole | Aripiprazole | 55 | 12 |
| Farxiga | Dapagliflozin Propanediol | 55 | suppressed |
| Cephalexin | Cephalexin | 54 | 23 |
| Entresto | Sacubitril/Valsartan | 53 | suppressed |
| Loperamide | Loperamide Hcl | 53 | 19 |
| Azithromycin | Azithromycin | 52 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 50 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 48 | suppressed |
| Glipizide | Glipizide | 48 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 47 | 11 |
| Alprazolam | Alprazolam | 46 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 45 | 20 |
| Folic Acid | Folic Acid | 45 | suppressed |
| Nyamyc | Nystatin | 45 | 21 |
| Fenofibrate | Fenofibrate | 44 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 44 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 44 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 43 | 37 |
| Doxazosin Mesylate | Doxazosin Mesylate | 43 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 25 |
| Oxybutynin Chloride | Oxybutynin Chloride | 43 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 42 | 17 |
| Linzess | Linaclotide | 42 | suppressed |
| Lovastatin | Lovastatin | 42 | suppressed |
| Olanzapine | Olanzapine | 42 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 42 | 27 |
| Diltiazem Hcl | Diltiazem Hcl | 41 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 13 |
| Metoclopramide Hcl | Metoclopramide Hcl | 39 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 38 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | 15 |
| Clonazepam | Clonazepam | 37 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 37 | 18 |
| Methylprednisolone | Methylprednisolone | 37 | 34 |
| Tramadol Hcl | Tramadol Hcl | 35 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 34 | 17 |
| Bupropion Hcl | Bupropion Hcl | 34 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | suppressed |
| Primidone | Primidone | 32 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | suppressed |
| Ibuprofen | Ibuprofen | 31 | suppressed |
| Lactulose | Lactulose | 31 | suppressed |
| Torsemide | Torsemide | 31 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 30 | suppressed |
| Budesonide | Budesonide | 29 | suppressed |
| Methotrexate | Methotrexate Sodium | 29 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 29 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Lidocaine | Lidocaine | 28 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Sucralfate | Sucralfate | 28 | suppressed |
| Cilostazol | Cilostazol | 27 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 26 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 26 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 26 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 23 | 21 |
| Fluconazole | Fluconazole | 23 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 23 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Movantik | Naloxegol Oxalate | 23 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 13 |
| Calcitriol | Calcitriol | 22 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Novolog | Insulin Aspart | 21 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 21 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Glyburide | Glyburide | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 16 |
| Silodosin | Silodosin | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Levemir Flexpen | Insulin Detemir | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | 15 |
| Methimazole | Methimazole | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Minoxidil | Minoxidil | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 13 |
| Cefdinir | Cefdinir | 15 | 11 |
| Cefuroxime | Cefuroxime Axetil | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 15 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 15 | suppressed |
| Jantoven | Warfarin Sodium | 15 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Verapamil Sr | Verapamil Hcl | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Enulose | Lactulose | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 14 | 12 |
| Nystop | Nystatin | 14 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 14 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 13 | suppressed |
| Galantamine Er | Galantamine Hbr | 13 | suppressed |
| Leucovorin Calcium | Leucovorin Calcium | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | suppressed |
| Mresvia | Rsv Vaccine, Pref, Mrna/Pf | 13 | 13 |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 12 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Dimethyl Fumarate | Dimethyl Fumarate | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 12 | suppressed |
| Neupro | Rotigotine | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Ursodiol | Ursodiol | 12 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $39.44 · 2 records | GlaxoSmithKline, LLC. | AREXVY, SHINGRIX | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error